Dr. Martens plc (LON:DOCS - Get Free Report) shot up 2.2% during trading on Wednesday . The stock traded as high as GBX 73.65 ($0.91) and last traded at GBX 73.26 ($0.91). 2,724,084 shares were traded during mid-day trading, an increase of 40% from the average session volume of 1,941,423 shares. The stock had previously closed at GBX 71.65 ($0.89).
Dr. Martens Stock Down 2.2 %
The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The company has a market capitalization of £703.78 million, a P/E ratio of 1,045.41, a PEG ratio of 6.40 and a beta of 0.11. The firm's 50 day moving average price is GBX 72.11 and its two-hundred day moving average price is GBX 65.51.
Dr. Martens (LON:DOCS - Get Free Report) last released its earnings results on Thursday, November 28th. The company reported GBX (1.30) (($0.02)) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 17.92%. Equities research analysts forecast that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. The ex-dividend date is Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens's dividend payout ratio is 4,285.71%.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
